$ICPT Recent Headlines U.S. stocks end lower; Dow turns

New Post Public Reply Private Reply Replies (0) Message Board

Aug 27, 2014 at 11:56 AM

$ICPT Recent Headlines

U.S. stocks end lower; Dow turns negative for the year 4:06 p.m. Aug. 12, 2014 - Anora Mahmudova
Skullcandy gains on upgrade,Tesla reverses gains 2:37 p.m. Aug. 12, 2014 - Sue Chang
Two drug makers diverge in Wall Street woods, and see huge moves 11:31 a.m. Aug. 12, 2014 - Russ Britt
Intercept shares surge after releasing positive liver drug data 8:04 a.m. Aug. 12, 2014 - Peter Loftus
Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - Russ Britt
Is biotech caught in a bubble, and is it popping? 1:13 p.m. April 8, 2014 - Russ Britt
Intercept investors see glass half empty as stock falls on drug news 4:32 p.m. March 17, 2014 - Russ Britt
This shocking strategy will save your portfolio 7:01 a.m. Jan. 15, 2014 - Jeff Reeves
Alnylam shares settle down after 40% gain; analysts are skeptical 2:16 p.m. Jan. 14, 2014 - Russ Britt
Intercept, Intuitive take diverging paths on the market roller coaster 11:51 a.m. Jan. 14, 2014 - Russ Britt
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 5:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Beam up on Suntory deal; Elliott report lifts Juniper 5:18 p.m. Jan. 13, 2014 - Sue Chang
Merck shares hit 52-week high on drug hopes, plans for cutbacks 1:31 p.m. Jan. 13, 2014 - Russ Britt
Intercept, Lululemon, SodaStream shares slump 11:22 a.m. Jan. 13, 2014 - Saumya Vaishampayan
S&P 500 gains for week; builder stocks rally as yields fall; the wonder of liver-drug stocks (live blog recap) 11:15 a.m. Jan. 13, 2014 - blogs.marketwatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 10:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Intercept shares trip short-sale circuit breaker 10:32 a.m. Jan. 13, 2014 - Laura Mandaro
Intercept, Celgene on move amid J.P. Morgan event 10:20 a.m. Jan. 13, 2014 - Victor Reklaitis
Banks, hedge funds and what Citi has to tell its rich clients 8:47 a.m. Jan. 13, 2014 - Shawn Langlois
Alcoa tops S&P losers, Twitter extends losing streak 5:29 p.m. Jan. 10, 2014 - Sue Chang

Insider Buys And Sells- Priceline, Southern Copper Corp. 11:17 a.m. Aug. 26, 2014 - Seeking Alpha
3 Biotechs Surging Following InterMune Takeover - Analyst Blog 11:07 a.m. Aug. 26, 2014 - Zacks.com
Conatus Pharmaceuticals Down On Low Enthusiasm For High Risk 4:28 p.m. Aug. 25, 2014 - Seeking Alpha
InterMune Stock Spikes On Rare Big Biotech Buyout 10:40 a.m. Aug. 25, 2014 - Investors Business Daily
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2014 Update 10:34 a.m. Aug. 23, 2014 - Seeking Alpha
Wedbush Securities' Liana Moussatos On The Art And Science Of Picking Biotechs With Upside 12:01 p.m. Aug. 22, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up: 8/18/14 6:18 a.m. Aug. 19, 2014 - Seeking Alpha
Should Gilead Sciences (GILD) Be in Your Portfolio? - Stocks in the News 1:00 p.m. Aug. 14, 2014 - Zacks.com
Intercept Pharmaceuticals Inc Stock Upgraded (ICPT) 11:12 a.m. Aug. 14, 2014 - TheStreet.com
Perilous Reversal Watch: Intercept Pharmaceuticals (ICPT) 9:58 a.m. Aug. 14, 2014 - TheStreet.com
Analysts' Actions: Cree, Intercept Pharma, Intermune, Tivo 7:39 a.m. Aug. 14, 2014 - TheStreet.com
Intercept Pharmaceuticals Posts Earnings, Pipeline in Focus - Analyst Blog 10:40 a.m. Aug. 13, 2014 - Zacks.com
Intercept Pharmaceuticals (ICPT) Worth Watching: Stock Gains 16.6% - Tale of the Tape 9:25 a.m. Aug. 13, 2014 - Zacks.com
'Fast Money' Recap: Stick With U.S. Stocks 5:00 a.m. Aug. 13, 2014 - TheStreet.com
U.S. Stocks End Lower 5:32 p.m. Aug. 12, 2014 - The Wall Street Journal Interactive Edition
Stock Market Today: Russian Sanctions and Oil in Focus 8/12/14 - Stocks in the News 3:33 p.m. Aug. 12, 2014 - Zacks.com
Intercept Pharma (ICPT) Shares Soar on Liver Disease Drug News - Stocks in the News 2:40 p.m. Aug. 12, 2014 - Zacks.com
Why Intercept Pharmaceuticals (ICPT) Stock Is Skyrocketing Today 12:54 p.m. Aug. 12, 2014 - InvestorPlace.com
Arrowhead's Hep B Phase 2a Topline Data Imminent - 'Transformational' Potential 12:27 p.m. Aug. 12, 2014 - Seeking Alpha
Intercept Pharma Soars On Liver-Disease Drug Data 9:48 a.m. Aug. 12, 2014 - Investors Business Daily

Intercept to Present at Upcoming Investor Conferences 8:05 a.m. Aug. 26, 2014 - GlobeNewswire
Drug Approvals, Financial Results, Market Activity, New Mobile Applications, and Company Updates - Research Reports on Intercept, Exact Sciences, Thermo Fisher Scientific, Illumina and Agilent 9:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Critical Alerts For GoPro, Intercept Pharmaceuticals, Pixelworks, Vertex Pharmaceuticals and General Mills. Released By InvestorsObserver 9:31 a.m. Aug. 13, 2014 - PR Newswire - PRF
Intercept to Host Second Quarter 2014 Update on August 11 and Present at Upcoming Investor Conference 5:01 p.m. Aug. 4, 2014 - GlobeNewswire
Galectin, Intercept, Others Vying for Lead Drugs in NASH Epidemic 10:03 a.m. July 24, 2014 - ACCESSWIRE
Intercept Pharmaceuticals Names Lazar Partners Agency of Record 10:08 a.m. July 10, 2014 - Marketwire
Catalysts on the Horizon for Companies Developing NAFLD and NASH Drugs 9:42 a.m. June 26, 2014 - ACCESSWIRE
Conference Presentations, Settlement and License Agreement, New Leadership, and Start of Phase III Study - Analyst Notes on Alexion, Mylan, Novartis, GSK and Intercept 5:50 a.m. June 11, 2014 - PR Newswire - PRF
FDA Approvals, Digital Health Guidance, Conference Presentations, and Recognitions - Analyst Notes on Intercept Pharmaceuticals, Cigna, Baxter, Questcor and Mallinckrodt 7:00 a.m. June 3, 2014 - PR Newswire - PRF
Technical Coverage of Health Care Sector Equities -- Research on Intercept Pharma, ACADIA Pharma, DENTSPLY Intl., and OraSure Technologies 11:42 a.m. May 15, 2014 - PR Newswire - PRF
Wall Street In and Out of Love with NASH Drug Developers 10:21 a.m. May 13, 2014 - ACCESSWIRE
Earnings Results, Agreements, Study Results, FDA Approvals, and Drug Trial Results - Analyst Notes on Merck, Johnson & Johnson, GlaxoSmithKline, Novartis and Intercept 8:00 a.m. May 12, 2014 - PR Newswire - PRF
Intercept Reports Additional Positive OCA Data in Patients With Bile Acid Diarrhea at Digestive Disease Week 4:06 p.m. May 6, 2014 - GlobeNewswire
Intercept to Host First Quarter 2014 Update on May 7 and Present at Upcoming Investor Conferences 6:06 a.m. May 1, 2014 - GlobeNewswire
Intercept Pharmaceuticals Appoints Rachel McMinn, Ph.D. as Chief Strategy Officer 4:50 p.m. April 30, 2014 - GlobeNewswire
Stock Price Movements, Updates on Clinical Studies, Financial Results Releases, and Company Response to New Laws - Analyst Notes on Perrigo, GlaxoSmithKline, Intercept, Centene and Lorillard 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Legal Updates, Stock Price Movements, New Awareness Campaigns, and Senior-level Appointments - Analyst Notes on Mylan, WellPoint, Forest, Novatis and Intercept 8:00 a.m. April 15, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Intercept Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- ICPT 4:01 a.m. April 14, 2014 - GlobeNewswire
Intercept Reports Additional Positive Data From POISE Trial at EASL Late-Breaker Session 12:00 p.m. April 12, 2014 - GlobeNewswire
Intercept Announces Preclinical Data Demonstrating OCA's Potential Role in Preventing Complications of Cirrhosis 9:04 a.m. April 11, 2014 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dar Global Eyes Dubai for Strategic Real Estate Moves

Tapping into Dubai's Real Estate Allure Every seasoned investor knows the real estate game ain't for the faint of heart, especially when you’re playing in a market as competitive as Dubai's. But here comes Dar Global Capital Partners (DGCP), throwing their hat into the ring with a fresh strategy centered around high-value real estate. Sure, they aren't new to the...

OncoHost's Research Links TKI Sensitivity to Biology

Cracking the Code on TKI Sensitivity When it comes to medicine, sometimes the trickiest part is knowing which button to push—especially in the high-stakes world of metastatic renal cell carcinoma (mRCC). OncoHost just dropped a bombshell at the ESMO 2026 Congress about their new plasma proteomics model that lets us peer into what makes some patients click with Tyrosine...

HONOR X9e Pro Unveils with Massive Battery Power

Lighting Up the Sky: HONOR's Big Move Picture this: the Burj Khalifa in Dubai, world’s tallest building, flashing with the promise of a smartphone's monstrous battery. That’s what the fine folks at HONOR did, highlighting their X9e Pro and its mind-boggling 11,000mAh battery. Now, am I the only one who finds it more than a little audacious to leverage such a flashy...

Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Sirha Lyon® 2027: A New Chapter in Foodservice

A Bold Step Forward There's a hearty aroma wafting from Lyon this January, and it's not just from the local gastronomy. Sirha Lyon® is queuing up for its 23rd edition, promising to turn the Foodservice and Hospitality sectors on their heads. Nearly 150,000 square meters of exhibition space packed to the rafters with over 4,300 exhibitors—this ain't your average trade...

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Love Business Group Helps SMEs Navigate Broadband Choices

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Elbit Systems Lands $200M APAC ISTAR Contracts

Elbit Systems Secures Major Asia-Pacific Deal You know, it's not every day that a defense contractor like Elbit Systems (NASDAQ:ESLT) bags a $200 million deal in the Asia-Pacific region. A big move in a high-stakes game where technology, strategy, and geography collide. This isn't some random supply deal; this involves the cutting edge of defense tech—ISTAR and training...